Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Tilray
|
| gptkbp:acquisition |
Aphria Inc.
|
| gptkbp:ceo |
gptkb:Irwin_Simon
|
| gptkbp:distribution |
Global
|
| gptkbp:founded |
gptkb:2018
|
| gptkbp:headquarters |
gptkb:Nanaimo,_British_Columbia,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tilray Innovations
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:market_cap |
Approximately $3 billion
|
| gptkbp:parent_company |
Tilray, Inc.
|
| gptkbp:partnership |
Various pharmaceutical companies
|
| gptkbp:products |
Cannabis products
|
| gptkbp:research_focus |
Cannabinoid research
|
| gptkbp:services |
Medical cannabis
Recreational cannabis |
| gptkbp:symbol |
gptkb:TLRY
|
| gptkbp:website |
www.tilray.com
|